Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Weinstock-Guttman

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsE Fisher, R A Rudick, G Cutter, et al.
Neurology|January 22, 2010
Increased tissue damage and lesion volumes in African Americans with multiple sclerosisB Weinstock-Guttman, M Ramanathan, K Hashmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening QuestionnaireR H B Benedict, J A Duquin, S Jurgensen, et al.
Neurology|September 19, 2007
Thalamic atrophy and cognition in multiple sclerosisM K Houtchens, R H B Benedict, R Killiany, et al.
European Journal of Neurology|August 2, 2019
Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-upN Murali, R W Browne, K Fellows Maxwell, et al.
Neurology|July 23, 1998
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosisD E Goodkin, R P Kinkel, B Weinstock-Guttman, et al.
AJNR. American Journal of Neuroradiology|June 13, 2015
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus ErythematosusB Cesar, M G Dwyer, J L Shucard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 27, 2009
Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosisR Zivadinov, M Zorzon, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
AJNR. American Journal of Neuroradiology|February 20, 2016
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple SclerosisR Zivadinov, B Raj, M Ramanathan, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsE Fisher, R A Rudick, G Cutter, et al.
Neurology|January 22, 2010
Increased tissue damage and lesion volumes in African Americans with multiple sclerosisB Weinstock-Guttman, M Ramanathan, K Hashmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening QuestionnaireR H B Benedict, J A Duquin, S Jurgensen, et al.
Neurology|September 19, 2007
Thalamic atrophy and cognition in multiple sclerosisM K Houtchens, R H B Benedict, R Killiany, et al.
European Journal of Neurology|August 2, 2019
Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-upN Murali, R W Browne, K Fellows Maxwell, et al.
Neurology|July 23, 1998
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosisD E Goodkin, R P Kinkel, B Weinstock-Guttman, et al.
AJNR. American Journal of Neuroradiology|June 13, 2015
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus ErythematosusB Cesar, M G Dwyer, J L Shucard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 27, 2009
Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosisR Zivadinov, M Zorzon, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
AJNR. American Journal of Neuroradiology|February 20, 2016
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple SclerosisR Zivadinov, B Raj, M Ramanathan, et al.
Pageof 11